{
  "image_filename": "table_p7_det_6_000.png",
  "image_path": "Grohskopf_et_al.__2023_/extracted/figures/table_p7_det_6_000.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_000",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A table listing available 2022\u201323 influenza vaccines by production method (Egg-based IIV4s and LAIV4, ccIIV4, RIV4) and the corresponding contraindications or precautions for individuals with prior severe allergic reactions to different vaccine types. The table provides guidance on contraindications and precautions for various influenza vaccine technologies but contains no information about clinical trial evaluations or head-to-head comparisons between Flublok (RIV4) and Fluarix; it does not support the claim. Note: The table focuses solely on allergy-related recommendations and does not address clinical trial design or comparator vaccines.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing available 2022\u201323 influenza vaccines by production method (Egg-based IIV4s and LAIV4, ccIIV4, RIV4) and the corresponding contraindications or precautions for individuals with prior severe allergic reactions to different vaccine types.",
    "evidence_found": null,
    "reasoning": "The table provides guidance on contraindications and precautions for various influenza vaccine technologies but contains no information about clinical trial evaluations or head-to-head comparisons between Flublok (RIV4) and Fluarix; it does not support the claim.",
    "confidence_notes": "The table focuses solely on allergy-related recommendations and does not address clinical trial design or comparator vaccines."
  }
}